Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News

FDA approves Darzalex Faspro for high-risk smoldering multiple myeloma

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent treatment for adult patients with high-risk smoldering multiple myeloma (HR-SMM).

FDA approves Caplyta for major depressive disorder in adults

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.

Family history key to predicting antidepressant response

A new study from Queen Mary University of London shows that a family's experience with certain medicines could help doctors predict how future generations will respond to the same drugs.

AI predicts when donor livers are viable, potentially slashing canceled transplants by 60%

There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a match is found with a donor who dies after cardiac arrest following the removal of life support, ...

Collaborations key to unlocking potential of AI in transforming medical education, say experts

Imagine a medical student diagnosing a virtual patient or a junior doctor practicing procedural skills such as drawing blood in a metaverse classroom. These Artificial Intelligence (AI)-powered tools aren't science fiction—they ...

Machine learning predicts drug response for personalized colorectal cancer treatment

A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform designed to "scan" the molecular features of each patient's cancer. Published in Cell Reports Medicine, ...

Todays Updates

Cancer care crowdfunding increasingly common, but rarely successful

A growing number of desperate cancer survivors are turning to crowdfunding to help pay for their treatment and living expenses, a new study says.

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets ...

Todays Updates

Cancer care crowdfunding increasingly common, but rarely successful

A growing number of desperate cancer survivors are turning to crowdfunding to help pay for their treatment and living expenses, a new study says.

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets ...

Latest News

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent treatment for adult patients with high-risk smoldering multiple myeloma (HR-SMM).

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.

A new study from Queen Mary University of London shows that a family's experience with certain medicines could help doctors predict how future generations will respond to the same drugs.

There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a match is found with a donor who dies after cardiac arrest following the removal of life support, ...

Imagine a medical student diagnosing a virtual patient or a junior doctor practicing procedural skills such as drawing blood in a metaverse classroom. These Artificial Intelligence (AI)-powered tools aren't science fiction—they ...

A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform designed to "scan" the molecular features of each patient's cancer. Published in Cell Reports Medicine, ...

News All Time

The hype and limits of at-home gut microbiome tests

The market for at-home gut microbiome tests is booming, with companies promising insights into health, chronic illness and even longevity through intestinal bacteria.

Engineering study takes 'quantum leap' to detect kidney disease

The kidney is one of the body's most vital organs, responsible for filtering waste, balancing electrolytes and maintaining overall health. Any impairment to its function can lead to serious and often irreversible consequences.

Once-weekly eloralintide leads to 20% weight loss in Phase II trial

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without type 2 diabetes.

Global use of antiseizure drug linked to birth defects is on the rise

In a study carried out in collaboration with the World Health Organization, two Aston University academics have found that while access to antiseizure medication in low- and middle-income countries is growing, it is not necessarily ...

Topology-aware deep learning model enhances EEG-based motor imagery decoding

Electroencephalography (EEG) is a fascinating noninvasive technique that measures and records the brain's electrical activity. It detects small electrical signals produced when neurons in the brain communicate with each other, ...

AI-based analysis of routine CT scans may also reveal weakened bones

Computed tomography (CT) scans of the chest, abdomen, and spine, taken originally to detect problems such as kidney stones or growths on the lungs, can be repurposed through artificial intelligence (AI) to catch signs of ...

AI tool in trial for faster prostate cancer diagnosis

The NHS is embarking on a trial that could cut prostate cancer diagnosis times from weeks to a single day. The initiative uses artificial intelligence to analyze MRI scans, potentially transforming care for men with the most ...

Nonsurgical treatment shows promise for targeted seizure control

Rice University bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit in an animal model. The team used low-intensity focused ultrasound to briefly open the blood-brain barrier (BBB) in ...

Tabletop blast device brings traumatic brain injury research to the lab bench

Four University of Rhode Island researchers have developed and tested a cost-effective, easy-to-use tabletop device that can generate pressure waves, mimicking the impact of blasts that can cause neurodegeneration. Their ...

VR headsets may actually reduce risk of dry eye

Virtual reality (VR) gaming has gained significant attention in recent years, with an increasing number of users integrating VR and immersive headsets into their daily lives. These devices provide highly immersive visuals, ...

Smart biomaterials can reduce chance of medical implant failure and accelerate patient recovery

A study conducted by the general and teaching hospital ("Hospital das Clínicas") of the Ribeirão Preto Medical School of the University of São Paulo (HCFMRP-USP) in Brazil followed 99 patients who underwent hip and knee ...

The FDA removes a long-standing warning from hormone-based menopause drugs

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced ...

Weight loss drug could help avoid need for follow-up bariatric surgery

Combining bariatric surgery with weight loss medication can help people who need to lose more weight post-surgery, Monash University and Alfred Health-led research has found.

New medication reduced high triglyceride levels, improved cholesterol and liver health

In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients with severe hypertriglyceridemia by more than 60%, according to a preliminary late-breaking science ...

Cannabis dispensaries lead to reduced opioid prescriptions: Studies among first to support plausible causation

Cannabis may be a pain-management substitute for people experiencing chronic or acute pain from conditions like cancer, according to new research from the University of Georgia.

AI model powers skin cancer detection across diverse populations

Researchers at the University of California San Diego School of Medicine have developed a new approach for identifying individuals with skin cancer that combines genetic ancestry, lifestyle and social determinants of health ...

Recommended News For You

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

Preventable pediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions

Glofitamab Regimen Improves Survival in DLBCL

As EGFR internalization is decreased, BUB1 controls EGFR signaling.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer

Recommended Articles For You

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results 

The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing 

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring 

Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

2.

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

3.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

4.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

5.

Why alarm is easing over a rise in pancreatic cancer among the young

1.

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs

2.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

3.

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology

4.

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights

5.

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

4.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot